MELIS María de Maeztu Unit of Excellence
The sustained scientific output and innovative organisation as a department of a public university, led MELIS to become one of six research units in Spain to be awarded the "María de Maeztu" (MdM) distinction by the Spanish Ministry of Economy, Industry and Competitiveness in its first call, in 2014. Notably, MELIS obtained its second MdM award (Agencia Estatal de Investigación, AEI) in 2018. These awards have enabled MELIS to broaden both its projection to society and its scientific visibility on a global scale.
The overarching scientific objective of the MELIS MdM scientific research program is to perform integrative and transformative biomedical research. One of the defining features of MELIS is its wide array of expertise in the life sciences, ranging from experimental, computational and theoretical basic research in biology and bioengineering, to biomedical applications and clinical research.
2. Research actions
Collaborative scientific projects
Internationalisation (visiting scientists)
Training: predoctoral fellows and courses
3. Research outcomes
Links to scientific news
Further information can be found in the 2021 report of the department (https://biomed.upf.edu/)
4. Scientific activities
MELIS Scientific "Pizza" seminars
On the 3rd Thursday of the month, MELIS hosts its scientific "Pizza" seminars. These sessions include two seminars by pre- and postdocs from different research groups, who can present and discuss their work in a friendly and open environment.
February 16, Charles Darwin room
- Jacob Smith, Cell Biology Group. Title: The Beat Goes On: Autonomy and Communication within the Circadian Clock Network
- Mireia Ramos-Rodríguez, Endocrine Regulatory Genomics Lab. Title: Noncoding regulatory functions in β-cell derived neuroendocrine tumors
March 16, Charles Darwin room
- Nerea Montedeoca, Neurobiology of Sensory Systems Group. Title: Sall1a is a transcription factor required for hair cell maturation in Danio rerio
- Georgina Fuentes, Endocrine Regulatory Genomics Group. Title: "Deciphering transcription factor dynamics in early stages of type 1 diabetes"
Future seminars are scheduled for April 20, May 18, June 15, and July 13.